Dr. Hönle AG

XTRA:HNL Stock Report

Market Cap: €47.9m

Dr. Hönle Future Growth

Future criteria checks 4/6

Dr. Hönle is forecast to grow earnings and revenue by 109.7% and 6.9% per annum respectively. EPS is expected to grow by 109.5% per annum. Return on equity is forecast to be 3.6% in 3 years.

Key information

109.7%

Earnings growth rate

109.5%

EPS growth rate

Electrical earnings growth26.1%
Revenue growth rate6.9%
Future return on equity3.6%
Analyst coverage

Low

Last updated17 Jan 2025

Recent future growth updates

Recent updates

Dr. Hönle AG's (ETR:HNL) Revenues Are Not Doing Enough For Some Investors

Jan 18
Dr. Hönle AG's (ETR:HNL) Revenues Are Not Doing Enough For Some Investors

The Price Is Right For Dr. Hönle AG (ETR:HNL) Even After Diving 26%

Sep 26
The Price Is Right For Dr. Hönle AG (ETR:HNL) Even After Diving 26%

Why Investors Shouldn't Be Surprised By Dr. Hönle AG's (ETR:HNL) P/S

Aug 06
Why Investors Shouldn't Be Surprised By Dr. Hönle AG's (ETR:HNL) P/S

Is There An Opportunity With Dr. Hönle AG's (ETR:HNL) 50% Undervaluation?

Jul 02
Is There An Opportunity With Dr. Hönle AG's (ETR:HNL) 50% Undervaluation?

Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear

Feb 08
Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear

We Think Dr. Hönle (ETR:HNL) Has A Fair Chunk Of Debt

Oct 11
We Think Dr. Hönle (ETR:HNL) Has A Fair Chunk Of Debt

Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Aug 07
Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Is Dr. Hönle (ETR:HNL) A Risky Investment?

Jun 03
Is Dr. Hönle (ETR:HNL) A Risky Investment?

The Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire Confidence

Nov 03
The Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire Confidence

Dr. Hönle (ETR:HNL) Has No Shortage Of Debt

Sep 29
Dr. Hönle (ETR:HNL) Has No Shortage Of Debt

There Are Reasons To Feel Uneasy About Dr. Hönle's (ETR:HNL) Returns On Capital

Jul 06
There Are Reasons To Feel Uneasy About Dr. Hönle's (ETR:HNL) Returns On Capital

Capital Allocation Trends At Dr. Hönle (ETR:HNL) Aren't Ideal

Feb 20
Capital Allocation Trends At Dr. Hönle (ETR:HNL) Aren't Ideal

Dr. Hönle AG (ETR:HNL) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jul 15
Dr. Hönle AG (ETR:HNL) Shares Could Be 37% Below Their Intrinsic Value Estimate

Is Dr. Hönle (ETR:HNL) A Risky Investment?

Jun 14
Is Dr. Hönle (ETR:HNL) A Risky Investment?

Is Dr. Hönle AG (ETR:HNL) Potentially Undervalued?

May 30
Is Dr. Hönle AG (ETR:HNL) Potentially Undervalued?

Dr. Hönle (ETR:HNL) Could Be Struggling To Allocate Capital

May 17
Dr. Hönle (ETR:HNL) Could Be Struggling To Allocate Capital

Calculating The Fair Value Of Dr. Hönle AG (ETR:HNL)

Mar 29
Calculating The Fair Value Of Dr. Hönle AG (ETR:HNL)

Do Investors Have Good Reason To Be Wary Of Dr. Hönle AG's (ETR:HNL) 1.0% Dividend Yield?

Mar 16
Do Investors Have Good Reason To Be Wary Of Dr. Hönle AG's (ETR:HNL) 1.0% Dividend Yield?

We Think Dr. Hönle (ETR:HNL) Is Taking Some Risk With Its Debt

Mar 03
We Think Dr. Hönle (ETR:HNL) Is Taking Some Risk With Its Debt

Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Feb 20
Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

We Wouldn't Rely On Dr. Hönle's (ETR:HNL) Statutory Earnings As A Guide

Feb 08
We Wouldn't Rely On Dr. Hönle's (ETR:HNL) Statutory Earnings As A Guide

Did Business Growth Power Dr. Hönle's (ETR:HNL) Share Price Gain of 131%?

Jan 25
Did Business Growth Power Dr. Hönle's (ETR:HNL) Share Price Gain of 131%?

Should We Be Excited About The Trends Of Returns At Dr. Hönle (ETR:HNL)?

Jan 11
Should We Be Excited About The Trends Of Returns At Dr. Hönle (ETR:HNL)?

What Kind Of Investors Own Most Of Dr. Hönle AG (ETR:HNL)?

Dec 27
What Kind Of Investors Own Most Of Dr. Hönle AG (ETR:HNL)?

Dr. Hönle AG (ETR:HNL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Dec 15
Dr. Hönle AG (ETR:HNL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Is Dr. Hönle AG (ETR:HNL) An Attractive Dividend Stock?

Dec 03
Is Dr. Hönle AG (ETR:HNL) An Attractive Dividend Stock?

These 4 Measures Indicate That Dr. Hönle (ETR:HNL) Is Using Debt Extensively

Nov 22
These 4 Measures Indicate That Dr. Hönle (ETR:HNL) Is Using Debt Extensively

Earnings and Revenue Growth Forecasts

XTRA:HNL - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2027122N/AN/AN/A1
9/30/20261124482
9/30/20251021162
9/30/202498-10382
6/30/202499-525N/A
3/31/2024101-1435N/A
12/31/2023103-1402N/A
9/30/2023106-1103N/A
6/30/2023109-10-3-2N/A
3/31/2023109-1-20N/A
12/31/20221131-32N/A
9/30/20221163-12-7N/A
6/30/2022118-3-16-5N/A
3/31/2022118-3-17-4N/A
12/31/2021119-3-20-6N/A
9/30/2021115-5-161N/A
6/30/20211076-145N/A
3/31/20211016-204N/A
12/31/2020955-216N/A
9/30/2020946-237N/A
6/30/2020988-2311N/A
3/31/202010310-1813N/A
12/31/201910310-1113N/A
9/30/201910812-217N/A
6/30/201911917116N/A
3/31/201912218518N/A
12/31/2018127211627N/A
9/30/2018127221424N/A
6/30/2018119191822N/A
3/31/201811617N/A18N/A
12/31/201711014N/A8N/A
9/30/201710210N/A7N/A
6/30/2017978N/A5N/A
3/31/2017969N/A8N/A
12/31/2016938N/A8N/A
9/30/2016948N/A9N/A
6/30/2016949N/A11N/A
3/31/2016939N/A10N/A
12/31/20159310N/A12N/A
9/30/20159310N/A9N/A
6/30/2015888N/A7N/A
3/31/2015868N/A6N/A
12/31/2014846N/A5N/A
9/30/2014826N/A7N/A
6/30/2014808N/A7N/A
3/31/2014827N/A7N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: HNL is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).

Earnings vs Market: HNL is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: HNL is expected to become profitable in the next 3 years.

Revenue vs Market: HNL's revenue (6.9% per year) is forecast to grow faster than the German market (5.5% per year).

High Growth Revenue: HNL's revenue (6.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: HNL's Return on Equity is forecast to be low in 3 years time (3.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/18 01:11
End of Day Share Price 2025/01/17 00:00
Earnings2024/06/30
Annual Earnings2023/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dr. Hönle AG is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tim WunderlichHauck Aufhäuser Investment Banking
Alina KohlerHauck Aufhäuser Investment Banking
Anish DixitVirtua Research Inc.